List of Excipients in API guaifenesin 600 mg
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing guaifenesin 600 mg
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| MARKSANS PHARMA LIMITED | guaifenesin 600 mg | 25000-042 | COPOVIDONE K25-31 |
| MARKSANS PHARMA LIMITED | guaifenesin 600 mg | 25000-042 | FD&C BLUE NO. 1 ALUMINUM LAKE |
| MARKSANS PHARMA LIMITED | guaifenesin 600 mg | 25000-042 | HYPROMELLOSE |
| MARKSANS PHARMA LIMITED | guaifenesin 600 mg | 25000-042 | MAGNESIUM STEARATE |
| MARKSANS PHARMA LIMITED | guaifenesin 600 mg | 25000-042 | MALTODEXTRIN |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for guaifenesin 600 mg
Excipient focus: CELLULOSE, MICROCRYSTALLINE
guaifenesin 600 mg drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| CVS Health Corp | guaifenesin 600 mg and pseudoephedrine hcl 60 mg | 69842-095 |
| >Company | >Ingredient | >NDC |
guaifenesin 600 mg drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| MARKSANS PHARMA LIMITED | guaifenesin 600 mg | 25000-042 |
| >Company | >Ingredient | >NDC |
Excipient focus: COPOVIDONE K25-31
guaifenesin 600 mg drug variants containing COPOVIDONE K25-31
| Company | Ingredient | NDC |
|---|---|---|
| MARKSANS PHARMA LIMITED | guaifenesin 600 mg | 25000-042 |
| >Company | >Ingredient | >NDC |
guaifenesin 600 mg drug variants not containing COPOVIDONE K25-31
| Company | Ingredient | NDC |
|---|---|---|
| CVS Health Corp | guaifenesin 600 mg and pseudoephedrine hcl 60 mg | 69842-095 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 1 ALUMINUM LAKE
guaifenesin 600 mg drug variants containing FD&C BLUE NO. 1 ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| MARKSANS PHARMA LIMITED | guaifenesin 600 mg | 25000-042 |
| >Company | >Ingredient | >NDC |
guaifenesin 600 mg drug variants not containing FD&C BLUE NO. 1 ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| CVS Health Corp | guaifenesin 600 mg and pseudoephedrine hcl 60 mg | 69842-095 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C YELLOW NO. 6
guaifenesin 600 mg drug variants containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| CVS Health Corp | guaifenesin 600 mg and pseudoephedrine hcl 60 mg | 69842-095 |
| >Company | >Ingredient | >NDC |
guaifenesin 600 mg drug variants not containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| MARKSANS PHARMA LIMITED | guaifenesin 600 mg | 25000-042 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
guaifenesin 600 mg drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| MARKSANS PHARMA LIMITED | guaifenesin 600 mg | 25000-042 |
| >Company | >Ingredient | >NDC |
guaifenesin 600 mg drug variants not containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| CVS Health Corp | guaifenesin 600 mg and pseudoephedrine hcl 60 mg | 69842-095 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSES
guaifenesin 600 mg drug variants containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| CVS Health Corp | guaifenesin 600 mg and pseudoephedrine hcl 60 mg | 69842-095 |
| >Company | >Ingredient | >NDC |
guaifenesin 600 mg drug variants not containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| MARKSANS PHARMA LIMITED | guaifenesin 600 mg | 25000-042 |
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
guaifenesin 600 mg drug variants containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| CVS Health Corp | guaifenesin 600 mg and pseudoephedrine hcl 60 mg | 69842-095 |
| >Company | >Ingredient | >NDC |
guaifenesin 600 mg drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| MARKSANS PHARMA LIMITED | guaifenesin 600 mg | 25000-042 |
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
guaifenesin 600 mg drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| MARKSANS PHARMA LIMITED | guaifenesin 600 mg | 25000-042 |
| CVS Health Corp | guaifenesin 600 mg and pseudoephedrine hcl 60 mg | 69842-095 |
| >Company | >Ingredient | >NDC |
guaifenesin 600 mg drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MALTODEXTRIN
guaifenesin 600 mg drug variants containing MALTODEXTRIN
| Company | Ingredient | NDC |
|---|---|---|
| MARKSANS PHARMA LIMITED | guaifenesin 600 mg | 25000-042 |
| >Company | >Ingredient | >NDC |
guaifenesin 600 mg drug variants not containing MALTODEXTRIN
| Company | Ingredient | NDC |
|---|---|---|
| CVS Health Corp | guaifenesin 600 mg and pseudoephedrine hcl 60 mg | 69842-095 |
| >Company | >Ingredient | >NDC |
Excipient focus: MICROCRYSTALLINE CELLULOSE 102
guaifenesin 600 mg drug variants containing MICROCRYSTALLINE CELLULOSE 102
| Company | Ingredient | NDC |
|---|---|---|
| MARKSANS PHARMA LIMITED | guaifenesin 600 mg | 25000-042 |
| >Company | >Ingredient | >NDC |
guaifenesin 600 mg drug variants not containing MICROCRYSTALLINE CELLULOSE 102
| Company | Ingredient | NDC |
|---|---|---|
| CVS Health Corp | guaifenesin 600 mg and pseudoephedrine hcl 60 mg | 69842-095 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE
guaifenesin 600 mg drug variants containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| CVS Health Corp | guaifenesin 600 mg and pseudoephedrine hcl 60 mg | 69842-095 |
| >Company | >Ingredient | >NDC |
guaifenesin 600 mg drug variants not containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| MARKSANS PHARMA LIMITED | guaifenesin 600 mg | 25000-042 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE K30
guaifenesin 600 mg drug variants containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| MARKSANS PHARMA LIMITED | guaifenesin 600 mg | 25000-042 |
| >Company | >Ingredient | >NDC |
guaifenesin 600 mg drug variants not containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| CVS Health Corp | guaifenesin 600 mg and pseudoephedrine hcl 60 mg | 69842-095 |
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
guaifenesin 600 mg drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| MARKSANS PHARMA LIMITED | guaifenesin 600 mg | 25000-042 |
| CVS Health Corp | guaifenesin 600 mg and pseudoephedrine hcl 60 mg | 69842-095 |
| >Company | >Ingredient | >NDC |
guaifenesin 600 mg drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A
guaifenesin 600 mg drug variants containing SODIUM STARCH GLYCOLATE TYPE A
| Company | Ingredient | NDC |
|---|---|---|
| MARKSANS PHARMA LIMITED | guaifenesin 600 mg | 25000-042 |
| >Company | >Ingredient | >NDC |
guaifenesin 600 mg drug variants not containing SODIUM STARCH GLYCOLATE TYPE A
| Company | Ingredient | NDC |
|---|---|---|
| CVS Health Corp | guaifenesin 600 mg and pseudoephedrine hcl 60 mg | 69842-095 |
| >Company | >Ingredient | >NDC |
Excipient focus: STEARIC ACID
guaifenesin 600 mg drug variants containing STEARIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| MARKSANS PHARMA LIMITED | guaifenesin 600 mg | 25000-042 |
| >Company | >Ingredient | >NDC |
guaifenesin 600 mg drug variants not containing STEARIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| CVS Health Corp | guaifenesin 600 mg and pseudoephedrine hcl 60 mg | 69842-095 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
